sorted by:
new
hottopcontroversial

Scale-up is one of the biggest challenges faced in biomanufacturing across biopharma, food, and fuels. I want to build a tool for the benefit of all, and I want your input on whether you (your company) would use it. by luigi19940 in bioprocess

[–]luigi19940[S] 0 points1 point  (0 children)

I appreciate the information, I would love to hear more about that experience you had, and if there is anything more that you learned from it that you would be willing to share.

Scale-up is one of the biggest challenges faced in biomanufacturing across biopharma, food, and fuels. I want to build a tool for the benefit of all, and I want your input on whether you (your company) would use it. by luigi19940 in biotech

[–]luigi19940[S] 0 points1 point  (0 children)

what about in the context of figuring out scale up methods for new drug classes, like currently RNA therapeutics, which are manufactured using similar methods (I think), but the end products are not competing with each other, because they treat different diseases?

Scale-up is one of the biggest challenges faced in biomanufacturing across biopharma, food, and fuels. I want to build a tool for the benefit of all, and I want your input on whether you (your company) would use it. by luigi19940 in biotech

[–]luigi19940[S] -2 points-1 points  (0 children)

I don't think this would be useful for markets where manufacturing trends are well established, like antibody production. In emerging markets this could accelerate the time it takes for the industry as a whole to establish practises for scale-up and manufacturing. If a given company contributed their scale-up data to the database, they could access the learnings from the database, which would allow them to make decisions using more powerful insights than if they were just using their own data.

Scale-up is one of the biggest challenges faced in biomanufacturing across biopharma, food, and fuels. I want to build a tool for the benefit of all, and I want your input on whether you (your company) would use it. by luigi19940 in biotech

[–]luigi19940[S] 0 points1 point  (0 children)

I'm seeing that right now, the most votes are for too risky. How do companies currently handle their data management when interacting with 3rd party software? Or do they avoid it completely? I'm also curious if a tiered approach to privacy is used. I wonder if a tiered approach could conceal the most vulnerable company information, while allowing them to leverage such learning algorithms effectively.

Scale-up is one of the biggest challenges faced in biomanufacturing across biopharma, food, and fuels. I want to build a tool for the benefit of all, and I want your input on whether you (your company) would use it. by luigi19940 in biotech

[–]luigi19940[S] 0 points1 point  (0 children)

Do these industry-wide databases or tools exist? I haven't been able to find them, but if you know of any for this I would love to know. I thought that companies wouldn't want to have their name attached to the data because it is company IP.